Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...
Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer ...
Longitudinal ctDNA measurements for treatment response monitoring in patients with metastatic colorectal cancer undergoing systemic therapy: The ORCA trial. This is an ASCO Meeting Abstract from the ...
Overall, 210 evaluable patients (n = 456 consented) received ≥1 US Food and Drug Administration–approved drug (mostly off label) after NGS. Median number of pathogenic alterations/tumor was five ...
Colorectal cancer, the second most common cause of cancer-related death, is mainly treated with chemotherapy, but its effectiveness decreases over time due to the progressive resistance of tumor cells ...
Morning Overview on MSN
Deadly toxin shocks scientists by freezing colon cancer in its tracks
A lethal bacterium best known for causing cholera is now at the center of one of the most surprising cancer stories of the ...
The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.
A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results